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Background: HIV-infected individuals have an increased risk for coronary artery disease; the factors implicated in this risk include HIV-associated 
inflammation, traditional risk factors, and antiretroviral therapy. Endothelial dysfunction is central to atherogenesis and is an indicator of coronary 
risk; however, the mechanisms reponsible for endothelial dysfunction in HIV are unknown. We hypothesized that endothelial dysfunction in HIV is 
related to heightened systemic inflammation as assessed by hsCRP.
Methods: We measured endothelial function as assessed by flow-mediated dilation (FMD) of the brachial artery in 98 antiretroviral treated and 
virally suppressed HIV-infected individuals and 32 uninfected controls. We compared FMD in HIV patients and controls and then assessed predictors 
of FMD in both groups after adjustment for traditional risk factors and HIV characteristics.
Results: The median age was 47 years (IQR 41-55), and 95% were male. The median duration of HIV infection was 17 years (IQR 13-21), and 
the median CD4 cell count was 217 cells/mm3 (IQR 183-282). Compared to controls, HIV-infected individuals had lower FMD (5.3% vs. 3.5% 
respectively, p=0.011) a finding that persisted after adjusting for traditional risk factors. The median hsCRP was higher in HIV patients compared 
to controls (2.4 mg/L vs. 1 mg/L, respectively, p=0.007), and a higher hsCRP was independently associated with HIV infection after adjustment for 
traditional risk factors (p=0.035). Among the HIV patients, higher hsCRP levels were a stronger predictor of impaired FMD compared to age (rho:-
0.21, p=0.034, rho:-0.08, p=0.38, respectively) while among controls, age was most predictive of FMD (rho:-0.48, p=0.004).
Conclusions: HIV patients on antiretroviral therapy with undetectable viral loads have endothelial dysfunction, a central mechanism in 
atherosclerosis and a marker of cardiovascular risk. This endothelial dysfunction is more closely related to systemic inflammation than traditional 
risk factors, suggesting that therapeutic strategies aimed at reducing HIV-related inflammation might restore endothelial function and thereby 
reduce cardiovascular risk.
